Patent application number | Description | Published |
20110092972 | Methods for Ultrasonic Tissue Sensing and Feedback - An ultrasonic surgical instrument including an ultrasonic transmission member having a proximal end and a distal end is provided. The instrument also includes an ultrasonically-actuated cutting element having a tissue contacting surface and a clamp member supported adjacent to the cutting element for clamping tissue. The clamp member includes a sensing mechanism that senses load variations. A handle member located at the proximal end of the transmission member moves the clamp member relative to the cutting element. Also, a feedback mechanism is operatively coupled to the sensing mechanism that supplies information related to the load variations where the output of the tissue cutting element is adjusted based on the sensed load variations. | 04-21-2011 |
20110137306 | Removable Ink for Surgical Instrument - The present disclosure relates to an apparatus and method for preventing reuse of a surgical instrument. The single-use surgical instrument includes a housing, an electrical connector and a treatment component. Indicia may be printed on the housing, the electrical connector and/or the treatment component. A removable ink is applied to any portion of the surgical instrument in the form of indicia that is readable by a scanning device. The removable ink includes a protein-based composition that is reactivateable with a sterilization solution having an enzyme-based composition such that upon sterilization, the removable ink reacts with the sterilizing solution and becomes unreadable by the scanning device. | 06-09-2011 |
20120010505 | Methods for Ultrasonic Tissue Sensing and Feedback - An ultrasonic surgical instrument is presented including an ultrasonic transmission member having a proximal end and a distal end, and a handle member located at the proximal end of the transmission member. The ultrasonic surgical instrument also includes an end effector assembly located at the distal end of the transmission member. The end effector assembly includes a sensing mechanism for sensing load variations on tissue based on mechanical vibrations detected on one or more portions of the surgical instrument, the mechanical vibrations sensed by a laser interferometer. | 01-12-2012 |
20120010604 | Methods for Ultrasonic Tissue Sensing and Feedback - An ultrasonic surgical instrument is presented including an ultrasonic transmission member having a proximal end and a distal end, and a handle member located at the proximal end of the transmission member. The ultrasonic surgical instrument also includes an end effector assembly located at the distal end of the transmission member. The end effector assembly includes a sensing mechanism for sensing load variations on tissue based on mechanical vibrations detected on one or more portions of the surgical instrument, the mechanical vibrations sensed by a laser interferometer. | 01-12-2012 |
20120191091 | Reusable Medical Device with Advanced Counting Capability - An electrosurgical instrument including a housing assembly having a first disposable treatment portion selectively attached thereto. The disposable treatment portion is adapted to connect to an electrosurgical generator that supplies energy to the electrosurgical instrument. A control circuit is included and disposed in electrical communication between the electrosurgical generator and the first disposable treatment portion. The control circuit is selectively actuatable to enable the flow of electrosurgical energy from the electrosurgical generator to the first disposable treatment portion. An indicator, coupled to the housing assembly or the first disposable treatment portion, is configured to indicate a parameter related to the use of the electrosurgical instrument. The control circuit is configured to prevent activation of the electrosurgical instrument when the parameter of the indicator indicates the useful life of the disposable treatment portion has expired. | 07-26-2012 |
20130261619 | REMOVABLE INK FOR SURGICAL INSTRUMENT - The present disclosure relates to an apparatus and method for preventing reuse of a surgical instrument. The single-use surgical instrument includes a housing, an electrical connector and a treatment component. Indicia may be printed on the housing, the electrical connector and/or the treatment component. A removable ink is applied to any portion of the surgical instrument in the form of indicia that is readable by a scanning device. The removable ink includes a protein-based composition that is reactivateable with a sterilization solution having an enzyme-based composition such that upon sterilization, the removable ink reacts with the sterilizing solution and becomes unreadable by the scanning device. | 10-03-2013 |
20140018796 | REMOVABLE INK FOR SURGICAL INSTRUMENT - The present disclosure relates to an apparatus and method for preventing reuse of a surgical instrument. The single-use surgical instrument includes a housing, an electrical connector and a treatment component. Indicia may be printed on the housing, the electrical connector and/or the treatment component. A removable ink is applied to any portion of the surgical instrument in the form of indicia that is readable by a scanning device. The removable ink includes a protein-based composition that is reactivateable with a sterilization solution having an enzyme-based composition such that upon sterilization, the removable ink reacts with the sterilizing solution and becomes unreadable by the scanning device. | 01-16-2014 |
20140350544 | REMOVABLE INK FOR SURGICAL INSTRUMENT - The present disclosure relates to an apparatus and method for preventing reuse of a surgical instrument. The single-use surgical instrument includes a housing, an electrical connector and a treatment component. Indicia may be printed on the housing, the electrical connector and/or the treatment component. A removable ink is applied to any portion of the surgical instrument in the form of indicia that is readable by a scanning device. The removable ink includes a protein-based composition that is reactivateable with a sterilization solution having an enzyme-based composition such that upon sterilization, the removable ink reacts with the sterilizing solution and becomes unreadable by the scanning device. | 11-27-2014 |
Patent application number | Description | Published |
20090285381 | PARKING AND ROUTING NETWORK CALLS AND SESSIONS - A device may process a call, receive a request to forward the call at a call extension point, obtain information about parked calls from a queue that stores information associated with the parked calls, determine whether the call may be parked or forwarded to a terminating device based on the information, park the call at the call extension point when it is determined that the call may not be forwarded, and forward the call to the terminating device when it is determined that the call may be forwarded. | 11-19-2009 |
20120155628 | LEAST COST CALL ROUTING - A device receives network information, least cost route (LCR) forecast information, network administrator inputs, and looping exceptions, and receives a call, from an originating location, to a terminating location. The device determines a LCR for the call based on the network information, the LCR forecast information, the network administrator inputs, and the looping exceptions. The device generates routing instructions for the determined LCR, and provides the routing instructions to one or more network elements associated with the determined LCR. The call is routed to the terminating location, via the one or more network elements associated with the determined LCR, and based on the routing instructions. | 06-21-2012 |
Patent application number | Description | Published |
20100331283 | Mitotic kinesin inhibitors and methods of use thereof - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 12-30-2010 |
20110144085 | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS - Compounds of Formula (I), in which A, B, R | 06-16-2011 |
20110144100 | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS - Compounds of Formula (I): I in which B, R | 06-16-2011 |
20120108568 | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS - Compounds of Formula (I) and salts thereof in which R | 05-03-2012 |
20140018399 | MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 01-16-2014 |
20140045817 | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS - Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I: | 02-13-2014 |
20140045835 | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS - Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: | 02-13-2014 |
20140094603 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 04-03-2014 |
20150031667 | Substituted Pyrazolo [1,5-A] Pyrimidine Compounds as TRK Kinase Inhibitors - Compounds of Formula I: | 01-29-2015 |
20150191490 | MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 07-09-2015 |
20150210658 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 07-30-2015 |
Patent application number | Description | Published |
20100029633 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS - Compounds of Formula I: in which A, B, R | 02-04-2010 |
20110184013 | Imidazo[1,2-a]Pyridine Compounds As Receptor Tyrosine Kinase Inhibitors - Compounds of Formula I and II: I II having the chemical names cis-6-fluoro-8-(3-fluoropiperidin-4-yloxy)-2-(7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl)quinoline and 6-fluoro-8-(trans-3-fluoropiperidin-4-yloxy)-2-(7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl)quinoline, respectively, and enantiomers and pharmaceutically acceptable salts thereof, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class 3 and class 5 receptor tyrosine kinases. The compounds of this invention have also been found to be inhibitors of Pim-1. | 07-28-2011 |
20110201651 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 08-18-2011 |
20120270803 | Mitotic Kinesin Inhibitors and Methods of Use Thereof - This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders. | 10-25-2012 |
20130109656 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF | 05-02-2013 |